This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Priveterra Acquisition II Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Priveterra Acquisition II's earnings have been declining at an average annual rate of -12.7%, while the Capital Markets industry saw earnings growing at 9.9% annually.
Belangrijke informatie
-12.7%
Groei van de winst
-79.3%
Groei van de winst per aandeel
| Capital Markets Groei van de industrie | 10.3% |
| Inkomstengroei | n/a |
| Rendement op eigen vermogen | n/a |
| Nettomarge | n/a |
| Laatste winstupdate | 30 Sep 2023 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Priveterra Acquisition II geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 23 | 0 | 1 | 5 | 0 |
| 30 Jun 23 | 0 | 2 | 5 | 0 |
| 31 Mar 23 | 0 | 0 | 4 | 0 |
| 31 Dec 22 | 0 | 7 | 4 | 0 |
| 30 Sep 22 | 0 | 12 | 2 | 0 |
| 30 Jun 22 | 0 | 14 | 1 | 0 |
| 31 Mar 22 | 0 | 7 | 1 | 0 |
| 31 Dec 21 | 0 | 9 | 1 | 0 |
Kwaliteitswinsten: PMGM has a large one-off gain of $2.3M impacting its last 12 months of financial results to 30th September, 2023.
Groeiende winstmarge: Insufficient data to determine if PMGM's profit margins have improved over the past year.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Insufficient data to determine if PMGM's year-on-year earnings growth rate was positive over the past 5 years.
Versnelling van de groei: PMGM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: PMGM had negative earnings growth (-91.3%) over the past year, making it difficult to compare to the Capital Markets industry average (6.2%).
Rendement op eigen vermogen
Hoge ROE: PMGM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.